CorMedix Inc. (NASDAQ:CRMD) Q2 2024 Earnings Call Transcript August 14, 2024
CorMedix Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.26.
Operator: Good day, and welcome to the CorMedix Inc. Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I’d now like to turn the conference over to your host today, Daniel Ferry. Please go ahead.
Dan Ferry: Good morning, and welcome to the CorMedix second...
